Overview

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

Status:
Recruiting
Trial end date:
2021-12-25
Target enrollment:
Participant gender:
Summary
This study aims to assess the safety and efficacy of dexmedetomidine versus ketamine versus midazolam combined with propofol in cancer patients undergoing gastrointestinal endoscopic procedures.
Phase:
N/A
Details
Lead Sponsor:
National Cancer Institute, Egypt
Treatments:
Dexmedetomidine
Ketamine
Midazolam
Propofol